Les androgènes sont des régulateurs clé de l’asthme allergique

Autor: Laffont, S.

Publikováno v: In Revue Française d'Allergologie April 2022 62(3):261-261

Sexual dimorphism in skin immunity is mediated by an androgen-ILC2-dendritic cell axis.

Autor: Chi L; Metaorganism Immunity Section, Laboratory of Host Immunity and Microbiome, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Liu C; Multiscale Systems Biology Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Gribonika I; Metaorganism Immunity Section, Laboratory of Host Immunity and Microbiome, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Gschwend J; Institute of Physiology, University of Zurich, CH-8057 Zürich, Switzerland., Corral D; Metaorganism Immunity Section, Laboratory of Host Immunity and Microbiome, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Han SJ; Metaorganism Immunity Section, Laboratory of Host Immunity and Microbiome, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Lim AI; Metaorganism Immunity Section, Laboratory of Host Immunity and Microbiome, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Rivera CA; Metaorganism Immunity Section, Laboratory of Host Immunity and Microbiome, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Link VM; Metaorganism Immunity Section, Laboratory of Host Immunity and Microbiome, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Wells AC; Metaorganism Immunity Section, Laboratory of Host Immunity and Microbiome, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Bouladoux N; Metaorganism Immunity Section, Laboratory of Host Immunity and Microbiome, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Collins N; Metaorganism Immunity Section, Laboratory of Host Immunity and Microbiome, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Lima-Junior DS; Metaorganism Immunity Section, Laboratory of Host Immunity and Microbiome, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Enamorado M; Metaorganism Immunity Section, Laboratory of Host Immunity and Microbiome, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Rehermann B; Immunology Section, Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Laffont S; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291, CNRS UMR5051, University Toulouse III, Toulouse, France., Guéry JC; Toulouse Institute for Infectious and Inflammatory Diseases (Infinity), INSERM UMR1291, CNRS UMR5051, University Toulouse III, Toulouse, France., Tussiwand R; National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD 20892, USA., Schneider C; Institute of Physiology, University of Zurich, CH-8057 Zürich, Switzerland., Belkaid Y; Metaorganism Immunity Section, Laboratory of Host Immunity and Microbiome, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.; NIAID Microbiome Program, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

Publikováno v: Science (New York, N.Y.) [Science] 2024 Apr 12; Vol. 384 (6692), pp. eadk6200. Date of Electronic Publication: 2024 Apr 12.

Différences liées au sexe dans l’asthme allergique : rôle des androgènes sur la biologie des cellules lymphoïdes innées de groupe 2

Autor: Laffont, S.

Publikováno v: In Revue Française d'Allergologie June 2020 60(4):270-271

¹⁸⁸ Re-SSS Lipiodol Radioembolization in HCC Patients: Results of a Phase 1 Trial (Lip-Re-01 Study).

Autor: Garin E; Department of Nuclear Medicine, Cancer Institute Eugène Marquis, F-35042 Rennes, France.; Campus Santé, University of Rennes, F-35042 Rennes, France.; INSERM, INRAE, Nutrition Métabolismes et Cancer U1317, University of Rennes, F-35033 Rennes, France., Palard X; Department of Nuclear Medicine, Cancer Institute Eugène Marquis, F-35042 Rennes, France.; Campus Santé, University of Rennes, F-35042 Rennes, France.; CLCC Eugène Marquis, Inserm, LTSI-UMR 1099, University of Rennes, F-35000 Rennes, France., Rolland Y; CLCC Eugène Marquis, Inserm, LTSI-UMR 1099, University of Rennes, F-35000 Rennes, France.; Department of Radiology, Cancer Institute Eugène Marquis, F-35042 Rennes, France., Le Sourd S; Department of Medical Oncology, Cancer Institute Eugène Marquis, F-35042 Rennes, France., Lepareur N; Department of Nuclear Medicine, Cancer Institute Eugène Marquis, F-35042 Rennes, France.; INSERM, INRAE, Nutrition Métabolismes et Cancer U1317, University of Rennes, F-35033 Rennes, France., Ardisson V; Department of Nuclear Medicine, Cancer Institute Eugène Marquis, F-35042 Rennes, France., Bouvry C; Department of Nuclear Medicine, Cancer Institute Eugène Marquis, F-35042 Rennes, France., Laffont S; Department of Nuclear Medicine, Cancer Institute Eugène Marquis, F-35042 Rennes, France., Campillo-Gimenez B; CLCC Eugène Marquis, Inserm, LTSI-UMR 1099, University of Rennes, F-35000 Rennes, France.; Department of Clinical Research, Cancer Institute Eugène Marquis, F-35042 Rennes, France., Bellissant E; Campus Santé, University of Rennes, F-35042 Rennes, France.; INSERM CIC 1414 (Clinical Investigation Center), F-35033 Rennes, France.; Department of Clinical and Biological Pharmacology and Pharmacovigilance, Pharmaco-Epidemiology and Drug Information Center, Rennes University Hospital, F-35033 Rennes, France., Edeline J; Campus Santé, University of Rennes, F-35042 Rennes, France.; Department of Medical Oncology, Cancer Institute Eugène Marquis, F-35042 Rennes, France.; INSERM, COSS (Chemistry Oncogenesis Stress Signaling)-UMR_S 1242, University of Rennes, F-35042 Rennes, France.

Publikováno v: Cancers [Cancers (Basel)] 2023 Apr 11; Vol. 15 (8). Date of Electronic Publication: 2023 Apr 11.

Targeting androgen signaling in ILC2s protects from IL-33-driven lung inflammation, independently of KLRG1.

Autor: Blanquart E; Institut Toulousain des Maladies Infectieuses et Inflammatoires (INFINITY), Université de Toulouse, CNRS, UPS, Toulouse, France., Mandonnet A; Institut Toulousain des Maladies Infectieuses et Inflammatoires (INFINITY), Université de Toulouse, CNRS, UPS, Toulouse, France., Mars M; Institut Toulousain des Maladies Infectieuses et Inflammatoires (INFINITY), Université de Toulouse, CNRS, UPS, Toulouse, France., Cenac C; Institut Toulousain des Maladies Infectieuses et Inflammatoires (INFINITY), Université de Toulouse, CNRS, UPS, Toulouse, France., Anesi N; Institut Toulousain des Maladies Infectieuses et Inflammatoires (INFINITY), Université de Toulouse, CNRS, UPS, Toulouse, France., Mercier P; Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse, CNRS, UPS, Toulouse, France., Audouard C; Centre de Biologie du Développement, Université de Toulouse, CNRS, UPS, Toulouse, France., Roga S; Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse, CNRS, UPS, Toulouse, France., Serrano de Almeida G; Department of Surgery & Cancer, Imperial College, London, United Kingdom., Bevan CL; Department of Surgery & Cancer, Imperial College, London, United Kingdom., Girard JP; Institut de Pharmacologie et de Biologie Structurale, Université de Toulouse, CNRS, UPS, Toulouse, France., Pelletier L; Institut Toulousain des Maladies Infectieuses et Inflammatoires (INFINITY), Université de Toulouse, CNRS, UPS, Toulouse, France., Laffont S; Institut Toulousain des Maladies Infectieuses et Inflammatoires (INFINITY), Université de Toulouse, CNRS, UPS, Toulouse, France. Electronic address: sophie.laffont-pradines@inserm.fr., Guéry JC; Institut Toulousain des Maladies Infectieuses et Inflammatoires (INFINITY), Université de Toulouse, CNRS, UPS, Toulouse, France. Electronic address: jean-charles.guery@inserm.fr.

Publikováno v: The Journal of allergy and clinical immunology [J Allergy Clin Immunol] 2022 Jan; Vol. 149 (1), pp. 237-251.e12. Date of Electronic Publication: 2021 May 05.